Is there a role for naturally occurring cyanobacterial toxins in neurodegeneration?. The beta-N-methylamino-l-alanine (BMAA) paradigm

Neurochemistry International

Volumn 50, Issue 7-8, 2007, Pages 998-1003

  Papapetropoulos, Spiridon ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

ALS PDC; BMAA; Cyanobacteria; Neurodegeneration; Neurotoxicity; Neurotoxins; Tauopathies

Indexed keywords

2 AMINO 3 METHYLAMINOPROPIONIC ACID; GLUTAMIC ACID;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; BRAIN TISSUE; CYANOBACTERIUM; DEGENERATIVE DISEASE; ECOSYSTEM; EXCITOTOXICITY; GUAM; HUMAN; IN VITRO STUDY; IN VIVO STUDY; NERVE DEGENERATION; PACIFIC ISLANDER; PRIORITY JOURNAL; PUBLIC HEALTH; SHORT SURVEY;

AMINO ACIDS, DIAMINO; DIET; GUAM; HUMANS; MOTOR NEURON DISEASE; NERVE DEGENERATION; NEURODEGENERATIVE DISEASES; NEUROTOXINS; PARKINSONIAN DISORDERS;

CYANOBACTERIA;

EID: 34250707847     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuint.2006.12.011     Document Type: Short Survey

References (61)

1. Armon C. Western Pacific ALS/PDC and flying foxes: what's next?. Neurology 61 (2003) 291-292
2. Banack S.A., and Cox P.A. Biomagnification of cycad neurotoxins in flying foxes: implications for ALS-PDC in Guam. Neurology 61 (2003) 387-389
3. Banack S.A., Murch S.J., and Cox P.A. Neurotoxic flying foxes as dietary items for the Chamorro people, Marianas Islands. J. Ethnopharmacol. 106 (2006) 97-104
4. Brownson D.M., Mabry T.J., and Leslie S.W. The cycad neurotoxic amino acid, beta-N-methylamino-l-alanine (BMAA), elevates intracellular calcium levels in dissociated rat brain cells. J. Ethnopharmacol. 82 (2002) 159-167
5. Cohen S.A., and Michaud D.P. Synthesis of a fluorescent derivatizing reagent, 6-aminoquinolyl-N-hydroxysuccinimidyl carbamate, and its application for the analysis of hydrolysate amino acids via high-performance liquid chromatography. Anal. Biochem. 211 (1993) 279-287
6. Cox P.A., Banack S., Murch S., and Sacks O. Commentary on: return of the cycad hypothesis-does the amyotrophic lateral sclerosis/Parkinsonism dementia complex (ALS/PDC) of Guam have new implications for global health?. Neuropathol. Appl. Neurobiol. 32 (2006) 679-682
7. Cox P.A., and Banack S.A. A nonprotein amino acid and neurodegeneration. Science 314 (2006) 1242
8. Cox P.A., Banack S.A., Murch S., Bell A., Nunn P., Bradley W.G., Mash D.C., Papapetropoulos S., Pablo J.P., Ronnevi L.-O., Conradi S., Bergman B., Rasmussen U., Bidigare R.R., Metcalf A.C.G., Johnson J.S., SpethR H., and Weiss J.H. Lack of ί-methylamino-l-alanine in brain from controls, AD, or Chamorros with PDC. Neurology 65 (2005) (e-letter)
9. Cox P.A., Banack S.A., and Murch S.J. Biomagnification of cyanobacterial neurotoxins and neurodegenerative disease among the Chamorro people of Guam. Proc. Natl. Acad. Sci. U.S.A. 100 (2003) 13380-13383
10. Cox P.A., and Sacks O.W. Cycad neurotoxins, consumption of flying foxes, and ALS-PDC disease in Guam. Neurology 58 (2002) 956-959
11. Cruz-Aguado R., Winkler D., and Shaw C.A. Lack of behavioral and neuropathological effects of dietary beta-methylamino-l-alanine (BMAA) in mice. Pharmacol. Biochem. Behav. 84 (2006) 294-299
12. Dawson Jr. R., Marschall E.G., Chan K.C., Millard W.J., Eppler B., and Patterson T.A. Neurochemical and neurobehavioral effects of neonatal administration of beta-N-methylamino-l-alanine and 3,3′-iminodipropionitrile. Neurotoxicol. Teratol. 20 (1998) 181-192
13. Dickson D.W. Required techniques and useful molecular markers in the neuropathologic diagnosis of neurodegenerative diseases. Acta Neuropathol. (Berl.) 109 (2005) 14-24
14. Duncan M.W., and Marini A.M. Debating the cause of a neurological disorder. Science 313 (2006) 1737
15. Duncan M.W., Steele J.C., Kopin I.J., and Markey S.P. 2-Amino-3-(methylamino)-propanoic acid (BMAA) in cycad flour: an unlikely cause of amyotrophic lateral sclerosis and parkinsonism-dementia of Guam. Neurology 40 (1990) 767-772
16. Forman M.S., Schmidt M.L., Kasturi S., Perl D.P., Lee V.M., and Trojanowski J.Q. Tau and alpha-synuclein pathology in amygdala of Parkinsonism-dementia complex patients of Guam. Am. J. Pathol. 160 (2002) 1725-1731
17. Galasko D., Salmon D.P., Craig U.K., Thal L.J., Schellenberg G., and Wiederholt W. Clinical features and changing patterns of neurodegenerative disorders on Guam, 1997-2000. Neurology 58 (2002) 90-97
18. Hamilton R.L. Lewy bodies in Alzheimer's disease: a neuropathological review of 145 cases using alpha-synuclein immunohistochemistry. Brain Pathol. 10 (2000) 378-384
19. Hirano A. Amyotrophic lateral sclerosis and parkinsonism-dementia complex on Guam: immunohistochemical studies. Keio J. Med. 41 (1992) 6-9
20. Hirano A., Kurland L.T., Krooth R.S., and Lessell S. Parkinsonism-dementia complex, an endemic disease on the island of Guam. I. Clinical features. Brain 84 (1961) 642-661
21. Hirano A., Malamud N., Elizan T.S., and Kurland L.T. Amyotrophic lateral sclerosis and Parkinsonism-dementia complex on Guam. Further pathologic studies. Arch. Neurol. 15 (1966) 35-51
22. Ince P.G., and Codd G.A. Return of the cycad hypothesis-does the amyotrophic lateral sclerosis/parkinsonism dementia complex (ALS/PDC) of Guam have new implications for global health?. Neuropathol. Appl. Neurobiol. 31 (2005) 345-353
23. Kazee A.M., and Han L.Y. Cortical Lewy bodies in Alzheimer's disease. Arch. Pathol. Lab. Med. 119 (1995) 448-453
24. Khabazian I., Bains J.S., Williams D.E., Cheung J., Wilson J.M., Pasqualotto B.A., Pelech S.L., Andersen R.J., Wang Y.T., Liu L., Nagai A., Kim S.U., Craig U.K., and Shaw C.A. Isolation of various forms of sterol beta-d-glucoside from the seed of Cycas circinalis: neurotoxicity and implications for ALS-parkinsonism dementia complex. J. Neurochem. 82 (2002) 516-528
25. Kisby G.E., Ellison M., and Spencer P.S. Content of the neurotoxins cycasin (methylazoxymethanol beta-d-glucoside) and BMAA (beta-N-methylamino-l-alanine) in cycad flour prepared by Guam Chamorros. Neurology 42 (1992) 1336-1340
26. Lippa C.F., Fujiwara H., Mann D.M., Giasson B., Baba M., Schmidt M.L., Nee L.E., O'Connell B., Pollen D.A., St George-Hyslop P., Ghetti B., Nochlin D., Bird T.D., Cairns N.J., Lee V.M., Iwatsubo T., and Trojanowski J.Q. Lewy bodies contain altered alpha-synuclein in brains of many familial Alzheimer's disease patients with mutations in presenilin and amyloid precursor protein genes. Am. J. Pathol. 153 (1998) 1365-1370
27. Lippa C.F., Schmidt M.L., Lee V.M., and Trojanowski J.Q. Antibodies to alpha-synuclein detect Lewy bodies in many Down's syndrome brains with Alzheimer's disease. Ann. Neurol. 45 (1999) 353-357
28. Maurizi C.P. Was a neurovirulent influenza virus the cause of amyotrophic lateral sclerosis and parkinsonism-dementia on Guam?. Med. Hypotheses 23 (1987) 325-326
29. Meyer V.R. Practical High-Performance Liquid Chromatography (2004), John Wiley & Sons, Chichester, United Kingdom
30. Monson C.S., Banack S.A., and Cox P.A. Conservation implications of Chamorro consumption of flying foxes as a possible cause of ALS-PDC in Guam. Conserv. Biol. 17 (2003) 678-686
31. Montine T.J., Li K., Perl D.P., and Galasko D. Lack of beta-methylamino-l-alanine in brain from controls, AD, or Chamorros with PDC. Neurology 65 (2005) 768-769
32. Mori H., Oda M., Komori T., Arai N., Takanashi M., Mizutani T., Hirai S., and Mizuno Y. Lewy bodies in progressive supranuclear palsy. Acta Neuropathol. (Berl.) 104 (2002) 273-278
33. Mori H., Yoshimura M., Tomonaga M., and Yamanouchi H. Progressive supranuclear palsy with Lewy bodies. Acta Neuropathol. (Berl.) 71 (1986) 344-346
34. Murch S.J., Cox P.A., and Banack S.A. A mechanism for slow release of biomagnified cyanobacterial neurotoxins and neurodegenerative disease in Guam. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 12228-12231
35. Murch S.J., Cox P.A., Banack S.A., Steele J.C., and Sacks O.W. Occurrence of beta-methylamino-l-alanine (BMAA) in ALS/PDC patients from Guam. Acta Neurol. Scand. 110 (2004) 267-269
36. Nedeljkov V., Lopicic S., Pavlovic D., and Cemerikic D. Electrophysiological effect of beta-N-methylamino-l-alanine on retzius nerve cells of the leech Haemopis sanguisuga. Ann. N. Y. Acad. Sci. 1048 (2005) 349-351
37. Papapetropoulos S., and Mash D.C. Alpha-synuclein aggregation and its relation to neurodegenerative diseases. Ann. Neurol. 57 (2005) 605 (author reply 605-606)
38. Perl D.P. Amyotrophic lateral sclerosis/parkinsonismdementia complex of Guam. In: Hof P.R., and Mobbs C.V. (Eds). Functional Neurobiology of Aging (2001), Academic Press, San Diego 183-201
39. Polymeropoulos M.H., Lavedan C., Leroy E., Ide S.E., Dehejia A., Dutra A., Pike B., Root H., Rubenstein J., Boyer R., Stenroos E.S., Chandrasekharappa S., Athanassiadou A., Papapetropoulos T., Johnson W.G., Lazzarini A.M., Duvoisin R.C., Di Iorio G., Golbe L.I., and Nussbaum R.L. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 276 (1997) 2045-2047
40. Rao S.D., Banack S.A., Cox P.A., and Weiss J.H. BMAA selectively injures motor neurons via AMPA/kainate receptor activation. Exp. Neurol. 201 (2006) 244-252
41. Reed D., Labarthe D., Chen K.M., and Stallones R. A cohort study of amyotrophic lateral sclerosis and parkinsonism-dementia on Guam and Rota. Am. J. Epidemiol. 125 (1987) 92-100
42. Reed D.M., and Brody J.A. Amyotrophic lateral sclerosis and parkinsonism-dementia on Guam, 1945-1972. I. Descriptive epidemiology. Am. J. Epidemiol. 101 (1975) 287-301
43. Reed D.M., Torres J.M., and Brody J.A. Amyotrophic lateral sclerosis and parkinsonism-dementia on Guam, 1945-1972. II. Familial and genetic studies. Am. J. Epidemiol. 101 (1975) 302-310
44. Rogaev E.I., Sherrington R., Rogaeva E.A., Levesque G., Ikeda M., Liang Y., Chi H., Lin C., Holman K., Tsuda T., et al. Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene. Nature 376 (1995) 775-778
45. Rosen D.R., Siddique T., Patterson D., Figlewicz D.A., Sapp P., Hentati A., Donaldson D., Goto J., O'Regan J.P., Deng H.X., et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362 (1993) 59-62
46. Sava V., Reunova O., Velasquez A., and Sanchez-Ramos J. Can low level exposure to ochratoxin-A cause parkinsonism?. J. Neurol. Sci. 249 (2006) 68-75
47. Schneider J.A., Watts R.L., Gearing M., Brewer R.P., and Mirra S.S. Corticobasal degeneration: neuropathologic and clinical heterogeneity. Neurology 48 (1997) 959-969
48. Spencer P.S., Ludolph A.C., and Kisby G.E. Neurologic diseases associated with use of plant components with toxic potential. Environ. Res. 62 (1993) 106-113
49. Spencer P.S., Nunn P.B., Hugon J., Ludolph A., and Roy D.N. Motorneurone disease on Guam: possible role of a food neurotoxin. Lancet 1 (1986) 965
50. Spencer P.S., Nunn P.B., Hugon J., Ludolph A.C., Ross S.M., Roy D.N., and Robertson R.C. Guam amyotrophic lateral sclerosis-parkinsonism-dementia linked to a plant excitant neurotoxin. Science 237 (1987) 517-522
51. Spencer P.S., Roy D.N., Ludolph A., Hugon J., Dwivedi M.P., and Schaumburg H.H. Lathyrism: evidence for role of the neuroexcitatory aminoacid BOAA. Lancet 2 (1986) 1066-1067
52. Spillantini M.G., Crowther R.A., Jakes R., Hasegawa M., and Goedert M. Alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies. Proc. Natl. Acad. Sci. U.S.A. 95 (1998) 6469-6473
53. Steele J.C. Parkinsonism-dementia complex of Guam. Mov. Disord. 20 Suppl. 12 (2005) S99-S107
54. Takahashi M., Billups B., Rossi D., Sarantis M., Hamann M., and Attwell D. The role of glutamate transporters in glutamate homeostasis in the brain. J. Exp. Biol. 200 (1997) 401-409
55. Trojanowski J.Q. Rotenone neurotoxicity: a new window on environmental causes of Parkinson's disease and related brain amyloidoses. Exp. Neurol. 179 (2003) 6-8
56. Trojanowski J.Q., Ishihara T., Higuchi M., Yoshiyama Y., Hong M., Zhang B., Forman M.S., Zhukareva V., and Lee V.M. Amyotrophic lateral sclerosis/parkinsonism dementia complex: transgenic mice provide insights into mechanisms underlying a common tauopathy in an ethnic minority on Guam. Exp. Neurol. 176 (2002) 1-11
57. Wakabayashi K., Fukushima T., Koide R., Horikawa Y., Hasegawa M., Watanabe Y., Noda T., Eguchi I., Morita T., Yoshimoto M., Iwatsubo T., and Takahashi H. Juvenile-onset generalized neuroaxonal dystrophy (Hallervorden-Spatz disease) with diffuse neurofibrillary and lewy body pathology. Acta Neuropathol. (Berl.) 99 (2000) 331-336
58. Weiss J.H., Koh J.Y., and Choi D.W. Neurotoxicity of beta-N-methylamino-l-alanine (BMAA) and beta-N-oxalylamino-l-alanine (BOAA) on cultured cortical neurons. Brain Res. 497 (1989) 64-71
59. Whiting M.G. Toxicity of cycads. Econ. Bot. 17 (1963) 271-302
60. Wilson J.M., Khabazian I., Wong M.C., Seyedalikhani A., Bains J.S., Pasqualotto B.A., Williams D.E., Andersen R.J., Simpson R.J., Smith R., Craig U.K., Kurland L.T., and Shaw C.A. Behavioral and neurological correlates of ALS-parkinsonism dementia complex in adult mice fed washed cycad flour. Neuromol. Med. 1 (2002) 207-221
61. Yamazaki M., Arai Y., Baba M., Iwatsubo T., Mori O., Katayama Y., and Oyanagi K. Alpha-synuclein inclusions in amygdala in the brains of patients with the parkinsonism-dementia complex of Guam. J. Neuropathol. Exp. Neurol. 59 (2000) 585-591